Sign in
Not yet recruitingNo phase

Lipid Management Gaps in Mexican Patients at High and Very High Cardiovascular Risk

Key facts

Who runs it
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Where
Mexico1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
1,600 people, planned
Starts
1 Jan 2027
Expected to end
28 Feb 2029
Type of study
Observational
Treatments tested
  • Lipid-Lowering Therapy in Routine Clinical Practice
Record updated
12 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Adults aged 18 years or older
  • Patients classified as having high or very high cardiovascular risk by their treating physician according to the 2019 European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) clinical risk categories
  • Patients currently receiving lipid-lowering therapy or with a clinical indication for lipid-lowering treatment
  • Availability of a baseline low-density lipoprotein cholesterol (LDL-C) measurement, either directly reported or calculable from a lipid profile obtained within the 12 months preceding enrollment
  • Life expectancy greater than one year, based on the treating physician's clinical judgment
  • Provision of written informed consent

Who cannot take part

  • No formal exclusion criteria are established in the study protocol
  • Participants for whom critical baseline variables, particularly an LDL-C measurement with its corresponding date, cannot be documented will not be eligible for the primary analysis dataset

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

SANTORINI-MX is a nationwide, multicenter, prospective, observational study designed to evaluate cholesterol management among adults in Mexico who are at high or very high risk of cardiovascular disease.

Read full original descriptionShow less

The main objective is to determine the proportion of patients who achieve the recommended low-density lipoprotein cholesterol (LDL-C) goals according to the 2019 European Society of Cardiology/European Atherosclerosis Society guidelines.

Approximately 1,600 adults will be enrolled from an initial network of 15 public and private healthcare centers across Mexico. Participants will be evaluated at enrollment and followed for approximately 12 months, with an allowable follow-up window of 10 to 14 months.

The study will collect information on cholesterol levels, cardiovascular risk factors, lipid-lowering medications, treatment changes, medication adherence, and barriers to optimal cholesterol management. Researchers will also examine whether treatment is intensified when LDL-C goals are not achieved.

This is a non-interventional study. Medical treatments and decisions will remain under the responsibility of each participant's treating physician, and no additional medical procedures will be required solely for research purposes.

The findings are expected to help identify gaps in cholesterol management in Mexico and inform future strategies to improve cardiovascular prevention and patient care.

The group in the trial

  • High and Very High Cardiovascular Risk Patients

    Adults aged 18 years or older classified as having high or very high cardiovascular risk according to the 2019 ESC/EAS guidelines, who are receiving or have a clinical indication for lipid-lowering therapy. Participants will be consecutively enrolled at participating healthcare centers in Mexico and assessed at baseline and after 12 ± 2 months. Lipid levels, cardiovascular risk factors, lipid-lowering treatments, treatment intensification, medication adherence, and barriers to optimal lipid management will be recorded. All treatments will be prescribed according to routine clinical practice, without protocol-assigned interventions.

    Treatment: Lipid-Lowering Therapy in Routine Clinical Practice

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
SANTORINI-MX: Lipid Management Gaps in Mexican Patients at High and Very High Cardiovascular Risk
Record updated
12 November 2026